Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Indianapolis, Indiana


Purpose:

The purpose of this study is to evaluate the safety of repeated doses of Botulinum Toxin Type A for the treatment of focal upper limb poststroke spasticity


Criteria:

Inclusion Criteria: - Medically stable poststroke patients with spastic muscles in the upper limb Exclusion Criteria: - Stroke within 6 months of study enrollment - Previous therapy with Botulinum Toxin Type A for treatment of any condition prior to 4 months of enrollment, for treatment of any condition prior to 01 January 1998


NCT ID:

NCT00651729


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

Indianapolis, Indiana
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.